We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-5.85%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.2B
AUM Growth
-$3.94B
Cap. Flow
-$1.12B
Cap. Flow %
-3.19%
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$63.8M
2
ALGN icon
Align Technology
ALGN
+$61.4M
3
STLA icon
Stellantis
STLA
+$54.4M
4
UBS icon
UBS Group
UBS
+$49.7M
5
RSG icon
Republic Services
RSG
+$44M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$73.1M
2
IPGP icon
IPG Photonics
IPGP
+$62.1M
3
ADBE icon
Adobe
ADBE
+$61.1M
4
UNH icon
UnitedHealth
UNH
+$56.3M
5
AAPL icon
Apple
AAPL
+$54.5M

Sector Composition

Rank Sector Weight
1 Technology 29.78%
2 Healthcare 17.08%
3 Financials 11.22%
4 Consumer Discretionary 10.87%
5 Industrials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRT icon
1201
Vertiv
VRT
$85.7B
– –
-23,600
Closed -$589K
WCC
1202
WESCO International
WCC
$15.1B
– –
-48,500
Closed -$6.38M
WSR
1203
DELISTED
Whitestone REIT
WSR
– –
-13,400
Closed -$136K
XEL icon
1204
Xcel Energy
XEL
$49.2B
– –
-29,903
Closed -$2.02M
XRX icon
1205
Xerox
XRX
$345M
– –
-22,700
Closed -$514K
ZLAB icon
1206
Zai Lab
ZLAB
$2.07B
– –
-338,991
Closed -$21.3M
ZM icon
1207
Zoom
ZM
$27.1B
– –
-1,535
Closed -$282K
ZTO icon
1208
ZTO Express
ZTO
$18.2B
– –
-34,403
Closed -$971K
VRN
1209
DELISTED
Veren
VRN
– –
-251,300
Closed -$1.34M
CONN
1210
DELISTED
Conn's Inc.
CONN
– –
-8,700
Closed -$205K
AYX
1211
DELISTED
Alteryx Inc
AYX
– –
-178,656
Closed -$10.8M
FRLN
1212
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-18,921
Closed -$562K
BKI
1213
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-2,611
Closed -$216K
SPPI
1214
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-26,100
Closed -$33K
JNCE
1215
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-15,100
Closed -$126K
SRNE
1216
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-29,800
Closed -$139K
LHCG
1217
DELISTED
LHC Group LLC
LHCG
– –
-84,100
Closed -$11.5M
MTOR
1218
DELISTED
MERITOR, Inc.
MTOR
– –
-9,800
Closed -$243K
MIME
1219
DELISTED
Mimecast Limited
MIME
– –
-63,900
Closed -$5.08M
CONE
1220
DELISTED
CyrusOne Inc Common Stock
CONE
– –
-167,383
Closed -$15M
ARNA
1221
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-3,300
Closed -$307K
INFO
1222
DELISTED
IHS Markit Ltd. Common Shares
INFO
– –
-1,505
Closed -$200K
VCRA
1223
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-11,300
Closed -$733K
CSLT
1224
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
– –
-21,100
Closed -$32K
XLNX
1225
DELISTED
Xilinx Inc
XLNX
– –
-6,324
Closed -$1.34M
46 47 48
49
50

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q1 2022 Portfolio in Review

As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Freshpet worth $30.3M.

  • Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
  • Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
  • Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
  • Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
  • Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
  • Axa opened 111 new positions and closed 94 in Q1 2022.
  • Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.